story of the week
Palbociclib, Pembrolizumab, and Letrozole in Hormone Receptor–Positive Metastatic Breast Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
European Journal of Cancer
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Phase I/II Trial of Palbociclib, Pembrolizumab and Letrozole in Patients With Hormone Receptor-Positive Metastatic Breast Cancer
Eur. J. Cancer 2021 Jul 01;154(xx)11-20, Y Yuan, JS Lee, SE Yost, PH Frankel, C Ruel, CA Egelston, W Guo, S Padam, A Tang, N Martinez, D Schmolze, C Presant, B Ebrahimi, C Yeon, M Sedrak, N Patel, J Portnow, P Lee, J MortimerFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.